Archives of Medical Research
Volume 37, Issue 6 , Pages 730-735 , August 2006

ΔmtDNA4977 Is More Common in Non-tumoral Cells from Gastric Cancer Sample

  • Behnam Kamalidehghan

      Affiliations

    • Department of Medical Genetics, National Institute for Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran
    • Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Putra, Malaysia
    • ,
  • Massoud Houshmand

      Affiliations

    • Department of Medical Genetics, National Institute for Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran
    • Corresponding Author InformationAddress reprint requests to: Massoud Houshmand, Head, Molecular Genetic Diagnostic Department, Department of Medical Genetics, National Institute for Genetic Engineering and Biotechnology, Pajoohesh Blvd. Tehran-Karaj Highway, 17th Km, P.O. Box:14155-6343, Tehran, Iran
    • ,
  • Patimah Ismail

      Affiliations

    • Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Putra, Malaysia
    • ,
  • Mehdi Shafa Shariat Panahi

      Affiliations

    • Department of Medical Genetics, National Institute for Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran
    • ,
  • Mohammad Hassan Hosseini Akbari

      Affiliations

    • Department of Pathology, Baghyatolah Hospital, Tehran, Iran

Received 20 October 2005 ,Accepted 3 February 2006.

References 

  1. Shenkar R, Navidi W, Tavaré S, Dang HM, Chomyn GA, Cortopassi G, et al. The mutation rate of the human mtDNA deletion mtDNA4977. Am J Hum Genet. 1996;50:772–780
  2. Correa PP, Haenszel W. Epidemiology of gastric cancer. In:  Correa P,  Haenszel W editor. Epidemiology of Cancer of the Digestive Tract, Vol. 2. The Hague: Martinus-Niijhoff; 1998;p. 58–84
  3. In:  Parkin DM,  Mujir CS,  Whelan SL,  Gao YT,  Ferlay J,  Powell J editor. Cancer Incidence in Five Continents, Vol. 6. Lyon: IARC Scientific Publication, No. 120; 1992;p. 865–870
  4. Nadim A, Noorai M. Cancers. In:  Azizi F,  Hatami H,  Janghorbani M editor. Epidemiology and Control of Common Diseases in Iran. 1st ed.. Tehran: Eshtiagh; 2000;p. 216–217
  5. Naghavi M. Death report from 10 provinces in Iran. 1st ed.. Tehran: Ministry of Health; 2000;
  6. Wallace DC. Mitochondrial DNA sequence variation in human evolution and disease. Proc Natl Acad Sci USA. 1994;91:8739–8746
  7. Yakes FM, Houten BV. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA. 1997;94:514–519
  8. Croteau DL, Bohr V. Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J Biol Chem. 1997;272:25409–25412
  9. Soslau G, Fuhrer JP, Nass MMK, Warren L. The effects of ethidium bromide on the membrane glycopeptides in control and virus transformed cells. J Biol Chem. 1974;249:3014–3020
  10. Pederson PL. Tumor mitochondria and the bioenergetics of cancer cells. Prog Exp Tumor Res. 1978;22:198–274
  11. Wilkie D, Evans I. Mitochondria and the yeast cell surface: implication for carcinogenesis. Trends Biochem Sci. 1982;7:147–151
  12. Israel BA, Schaeffer WI. Cytoplasmic suppression of malignancy. In Vitro Cell Dev Biol. 1987;23:627–632
  13. Israel BA, Schaeffer WI. Cytoplasmic mediation of malignancy. In Vitro Cell Dev Biol. 1988;24:487–497
  14. Hayashi JI, Takemitsu M, Nonaka I. Recovery of the missing tumorigenicity in mitochondrial DNA-less HeLa cells by introduction of mitochondrial DNA from normal human cells. Somat Cell Mol Genet. 1992;18:123–129
  15. Baggetto LG. Role of mitochondria in carcinogenesis. Eur J Cancer. 1992;29A:156–159
  16. Morais R, Zinkewich PK, Parent M, Wang H, Babai F, Zollinger M. Tumor forming ability in athymic nude mice of human cell lines devoid of mitochondrial DNA. Cancer Res. 1994;54:3889–3896
  17. Bianchi MS, Bianchi NO, Bailiet G. Mitochondrial DNA mutations in normal and tumor tissue from breast cancer patients. Cytogenet Cell Gene. 1995;71:99–103
  18. Liang BC, Hays L. Mitochondrial DNA copy number changes in human gliomas. Cancer Lett. 1996;105:167–173
  19. Cavalli LR, Varella GM, Liang BC. Diminished tumorigenic phenotype after depletion of mitochondrial DNA. Cell Growth Differ. 1997;8:1189–1198
  20. Dani SU, Dani MAC, Simpson AJG. The common mitochondrial DNA deletion ΔmtDNA4977: shedding new light on the concept of a tumor suppressor mutation. Med Hypotheses. 2003;61:60–63
  21. Cortopassi GA, Arnheim N. Detection of a specific mitochondrial DNA deletion in tissues of older individuals. Nucleic Acids Res. 1990;18:6927–6933
  22. Corral DM, Stepian G, Shoffner JM, Lott MT, Kanter K, Wallace DC. Hypoxemia is associated with mitochondrial DNA damage and gene induction: implications for cardiac disease. JAMA. 1991;266:1812–1816
  23. Hattori K, Tanaka M, Sugiyama S, Obayashi T, Ito T, Satake T, et al. Age dependent increase in deleted mitochondrial DNA in the human heart: possible contributory factor to presbycardia. Am Heart J. 1991;121:1735–1742
  24. Yen TC, Sue JH, King KL, Wei YH. Aging associated 5-kb deletion in human liver mitochondrial DNA. Biochem Biophys Res Commun. 1991;178:124–131
  25. Cortopassi GA, Shibata D, Soong NW, Arnheim N. A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues. Proc Natl Acad Sci USA. 1992;89:7370–7374
  26. Zhang C, Baumer A, Maxwell RJ, Linnane AW, Nagley P. Multiple mtDNA deletions in an elderly individual. FEBS Lett. 1992;297:34–38
  27. Shi SR, Cote RJ, Wu L, Liu C, Datar R, Shi Y, et al. DNA extraction from archival formalin-fixed, paraffin-embedded tissue sections based on the antigen retrieval principle: heating under the influence of pH. J Histochem Cytochem. 2002;50:1005–1011
  28. Fang DC, Wang RQ, Yang SM, Yang JM, Liu HF, Peng GY, et al. Mutation and methylation of hMLH1 in gastric carcinomas with microsatellite instability. World J Gastroenterol. 2003;9:655–659
  29. Fang DC, Luo YH, Yang SM, Li XA, Ling XL, Fang L. Mutation analysis of APC gene in gastric cancer with microsatellite instability. World J Gastroenterol. 2002;8:787–791
  30. Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, et al. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science. 2000;287:2017–2019
  31. Richard SM, Bailliet G, Paez GL, Bianchi MS, Peltomaki P, Bianchi NO. Nuclear and mitochondrial genome instability in human breast cancer. Cancer Res. 2000;60:4231–4237
  32. Yeh JJ, Lunetta KL, van Orsouw NJ, Moore FD, Mutter GL, Vijg J, et al. Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours. Oncogene. 2000;19:2060–2066
  33. Habano W, Sugai T, Yoshida T, Nakamura S. Mitochondrial gene mutation, but not large-scale deletion, is a feature of colorectal carcinomas with mitochondrial microsatellite instability. Int J Cancer. 1999;83:625–629
  34. Wu MS, Shun CT, Wang HP, Sheu JC, Lee WJ, Wang TH, et al. Genetic alterations in gastric cancer: relation to histological subtypes, tumor stage, and Helicobacter pylori infection. Gastroenterology. 1997;112:1457–1465
  35. Endoh Y, Sakata K, Tamura G, Ohmura K, Ajioka Y, Watanabe H, et al. Cellular phenotypes of differentiated-type adenocarcinomas and precancerous lesions of the stomach are dependent on the genetic pathways. J Pathol. 2000;191:257–263
  36. Ohmura K, Tamura G, Endoh Y, Sakata K, Takahashi T, Motoyama T. Microsatellite alterations in differentiated-type adenocarcinomas and precancerous lesions of the stomach with special reference to cellular phenotype. Hum Pathol. 2000;31:1031–1035
  37. Xian LL, Dian CF, Rong QW, Shi MY, Li F. Mitochondrial microsatellite instability in gastric cancer and its precancerous lesions. World J Gastroenterol. 2004;10(6):800–803
  38. Hochhauser D. Relevance of mitochondrial DNA in cancer. Lancet. 2000;356:181–182
  39. Liu MR, Pan KF, Li ZF, Wang Y, Deng DJ, Zhang L, et al. Rapid screening mitochondrial DNA mutation by using denaturing high-performance liquid chromatography. World J Gastroenterol. 2002;8:426–430
  40. Shen ZY, Shen J, Li QS, Chen CY, Chen JY, Zeng Y. Morphological and functional changes of mitochondria in apoptotic esophageal carcinoma cells induced by arsenic trioxide. World J Gastroenterol. 2002;8:31–35
  41. Peters U, Preisler-Adams S, Lanvers-Kaminsky C, Jurgens H, Lamprecht-Dinnesen A. Sequence variations of mitochondrial DNA and individual sensitivity to the ototoxic effect of cisplatin. Anticancer Res. 2003;23:1249–1255
  42. Carew JS, Zhou Y, Albitar M, Carew JD, Keating MJ, Huang P. Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implications. Leukemia. 2003;17:1437–1447
  43. Wardell TM, Ferguson E, Chinnery PF, Borthwick GM, Taylor RW, Jackson G, et al. Changes in the human mitochondrial genome after treatment of malignant disease. Mutat Res. 2003;525:19–27
  44. Tallini G, Ladanyi M, Rosai J, Jhanwar SC. Analysis of nuclear and mitochondrial DNA alterations in thyroid and renal oncocytic tumors. Cytogenet Cell Genet. 1994;66:253–259
  45. Fukushima S, Honda K, Awane M, Yamamoto E, Takeda R, Kaneko I, et al. The frequency of 4977 base pair deletion of mitochondrial DNA in various types of liver disease and in normal liver. Hepatology. 1995;21:1547–1551
  46. Wallace DG. Mitochondrial diseases: genotype versus phenotype. TIG. 1993;9:128–133
  47. Li JM, Cai Q, Zhou H, Xiao GX. Effects of hydrogen peroxide on mitochondrial gene expression of intestinal epithelial cells. World J Gastroenterol. 2002;8:1117–1122

PII: S0188-4409(06)00093-2

doi: 10.1016/j.arcmed.2006.02.005

Archives of Medical Research
Volume 37, Issue 6 , Pages 730-735 , August 2006

Article Tools

* Image Usage & Resolution